Tenet Healthcare CorporationTHCNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -5.71% | -2.70% | +3.29% | +3.26% | +8.97% |
| Gross Profit Growth | -3.99% | +3.68% | +114.27% | +52.65% | +12.17% |
| EBITDA Growth | +9.25% | -66.52% | +5.81% | -14.78% | +4.66% |
| Operating Income Growth | +11.70% | -71.29% | +8.15% | -18.37% | +3.90% |
| Net Income Growth | +30.33% | -81.13% | +11.20% | -27.54% | +16.67% |
| EPS Growth | +38.02% | -80.05% | +18.80% | -21.10% | +27.25% |
| EPS Diluted Growth | +44.35% | -80.03% | +18.94% | -21.06% | +27.11% |
| Weighted Average Shares Growth | -5.80% | -5.36% | -6.30% | -8.06% | -7.56% |
| Weighted Average Shares Diluted Growth | -7.95% | -5.55% | -6.76% | -8.32% | -8.31% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -140.17% | +39.08% | +25.30% | +1.24% | +0.00% |
| Free Cash Flow Growth | -207.31% | +91.07% | +23.42% | -7.27% | +0.00% |
| Receivables Growth | -10.28% | -12.71% | +11.14% | +23.75% | -16.01% |
| Inventory Growth | -15.82% | -12.91% | -11.52% | -2.81% | +0.58% |
| Asset Growth | +2.20% | +1.14% | -1.93% | +0.16% | +2.56% |
| Book Value per Share Growth | +175.36% | +27.94% | +15.14% | +13.88% | +9.45% |
| Debt Growth | -12.19% | +2.26% | +2.36% | +2.46% | -0.02% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -0.24% | -6.80% | +1957.14% | +1959.81% | -100.00% |